Skip to main content
Premium Trial:

Request an Annual Quote

FTC Wants More Information About BGI-Shenzhen Buy of Complete Genomics

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has made a second request to Complete Genomics and BGI-Shenzhen requesting additional information about BGI's proposed $117.6 million purchase of Complete Genomics, the Mountain View, Calif-based sequencing services firm said in a document filed with the US Securities and Exchange Commission on Friday.

As a result, the waiting period applicable under the Hart-Scott-Rodino Antitrust Improvement Act of 1976 has been extended beyond the original date of 11:59 PM EDT Oct. 31. The waiting period will now expire at 11:59 ET on the 10th day after Complete Genomics and BGI comply with FTC's request.

Last month, BGI extended its tender offer for Complete Genomics to midnight Nov. 21. It originally was to expire midnight, Oct. 23.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.